Enanta Pharmaceuticals, Inc. (ENTA) has a market capitalization of $339.66M and trades at $14.63. The 52-week range is 4.09-17.15.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.8, Earnings Per Share (EPS) of $-3.84, annual revenue of $65.32M.
The stock has a beta of 1.00, operates in the Healthcare sector.
